Cargando…

Cost-Effectiveness of Baricitinib Compared With Standard of Care: A Modeling Study in Hospitalized Patients With COVID-19 in the United States

PURPOSE: In the Phase III COV-BARRIER (Efficacy and Safety of Baricitinib for the Treatment of Hospitalised Adults With COVID-19) trial, treatment with baricitinib, an oral selective Janus kinase 1/2 inhibitor, in addition to standard of care (SOC), was associated with significantly reduced mortalit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ohsfeldt, Robert, Kelton, Kari, Klein, Tim, Belger, Mark, Mc Collam, Patrick L., Spiro, Theodore, Burge, Russel, Ahuja, Neera
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Authors. Published by Elsevier Inc. 2021
Materias:	COVID Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8487786/ https://www.ncbi.nlm.nih.gov/pubmed/34732289 http://dx.doi.org/10.1016/j.clinthera.2021.09.016

Ejemplares similares

Cost-Effectiveness of Combination of Baricitinib and Remdesivir in Hospitalized Patients with COVID-19 in the United States: A Modelling Study
por: Kelton, Kari, et al.
Publicado: (2021)

Inpatient Hospital Costs for COVID-19 Patients in the United States
por: Ohsfeldt, Robert L., et al.
Publicado: (2021)

Organ damage in patients treated with belimumab versus standard of care: a propensity score-matched comparative analysis
por: Urowitz, Murray B, et al.
Publicado: (2019)

The Impact of the COVID-19 Pandemic on Vascular Surgery Trainees in the United States
por: Johnson, Adam P., et al.
Publicado: (2021)

Challenges in the Practice of Sexual Medicine in the Time of COVID-19 in the United States
por: Shindel, Alan W., et al.
Publicado: (2020)

The COVID-19 Pandemic and Antibiotic Use on the United States–Mexico Border
por: Khan, Sana, et al.
Publicado: (2021)

Baricitinib for patients with severe COVID-19—time to change the standard of care?
por: Supady, Alexander, et al.
Publicado: (2022)

We Need to Talk About Rationing: The Need to Normalize Discussion About Healthcare Rationing in a Post COVID-19 Era
por: Bhatia, Neera
Publicado: (2020)

Estimated preventable COVID-19-associated deaths due to non-vaccination in the United States
por: Jia, Katherine M., et al.
Publicado: (2023)

Trends in gastrointestinal infections before and during non-pharmaceutical interventions in Korea in comparison with the United States
por: Kim, Soyeoun, et al.
Publicado: (2022)

Application of Baricitinib in Dermatology
por: Zhang, Jingya, et al.
Publicado: (2022)

Concurrent SARS-COV-19 and acute appendicitis: Management and outcomes across United States children’s hospitals
por: Iantorno, Stephanie E., et al.
Publicado: (2023)

Total First-Year Costs of Acute Coronary Syndrome in a Managed Care Setting
por: Etemad, Lida R., et al.
Publicado: (2005)

Cost-impact analysis of baroreflex activation therapy in chronic heart failure patients in the United States
por: Bisognano, John, et al.
Publicado: (2021)

Tibia shaft fractures: costly burden of nonunions
por: Antonova, Evgeniya, et al.
Publicado: (2013)

Reactogenicity to COVID-19 vaccination in the United States of America
por: Sanyaolu, Adekunle, et al.
Publicado: (2022)

A Cost-Benefit Analysis of Lipid Standardization in the United States
por: Hoerger, Thomas J., et al.
Publicado: (2011)

Challenges in Evaluating the Cost-Effectiveness of Statins
por: Ohsfeldt, Robert L.
Publicado: (2004)

The United States’ reckoning with racism during the COVID-19 pandemic: What can we learn and do as allergist-immunologists?
por: Wright, Lakiea S., et al.
Publicado: (2021)

Associations of racial and ethnic discrimination with adverse changes in exercise and screen time during the COVID-19 pandemic in the United States
por: Xia, Tong, et al.
Publicado: (2023)

Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19
por: Kalil, Andre C., et al.
Publicado: (2020)

COVID‐19: Implications for Nursing and Health Care in the United States
por: Reynolds, Nancy R., et al.
Publicado: (2022)

Dermatologist and Patient Perceptions of Treatment Success in Alopecia Areata and Evaluation of Clinical Outcome Assessments in Japan
por: Macey, Jake, et al.
Publicado: (2021)

Baricitinib for the treatment of rheumatoid arthritis
por: Urits, Ivan, et al.
Publicado: (2020)

Baricitinib and primary biliary cholangitis
por: Gordon, Stuart C., et al.
Publicado: (2021)

Baricitinib for the Treatment of Alopecia Areata
por: Freitas, Egídio, et al.
Publicado: (2023)

Baricitinib + SOC cost effective vs SOC for patients hospitalised with COVID-19 in the USA
Publicado: (2021)

Baricitinib + remdesivir cost saving vs remdesivir for hospitalised COVID-19 patients in the USA
Publicado: (2021)

CRT-200.02 National Trends of Structural Heart Disease Interventions From 2016 to 2020 in the United States and the Associated Impact of COVID-19 Pandemic
por: Maraey, Ahmed, et al.
Publicado: (2023)

Baricitinib Treatment of Coronavirus Disease 2019 Is Associated With a Reduction in Secondary Infections
por: Sweeney, Daniel A, et al.
Publicado: (2023)

Synergistic Disparities and Public Health Mitigation of COVID-19 in the Rural United States
por: Chillag, Kata L., et al.
Publicado: (2020)

Efficacy and Safety of Baricitinib in Patients with Severe Alopecia Areata over 52 Weeks of Continuous Therapy in Two Phase III Trials (BRAVE-AA1 and BRAVE-AA2)
por: Kwon, Ohsang, et al.
Publicado: (2023)

The Pandemic League of COVID-19: Korea Versus the United States, With Lessons for the Entire World
por: Issac, Alwin, et al.
Publicado: (2020)

Cost-effectiveness analysis of baricitinib versus adalimumab for the treatment of moderate-to-severe rheumatoid arthritis in Spain
por: Schlueter, Max, et al.
Publicado: (2019)

Cost-Effectiveness of Baricitinib for Patients with Moderate-to-Severe Rheumatoid Arthritis After Methotrexate Failed in China
por: Li, SiNi, et al.
Publicado: (2021)

Cost-Effectiveness of Tamsulosin, Doxazosin, and Terazosin in the Treatment of Benign Prostatic Hyperplasia
por: Ohsfeldt, Robert L., et al.
Publicado: (2004)

15. Eosinophilic pneumonitis secondary to baricitinib
por: Yein, Khin, et al.
Publicado: (2019)

Treatment of severe alopecia areata with baricitinib
por: Olamiju, Brianna, et al.
Publicado: (2019)

Baricitinib: Two Birds with One Stone
por: Saj, Fen, et al.
Publicado: (2022)

Efficacy and Safety of Garadacimab in Combination with Standard of Care Treatment in Patients with Severe COVID-19
por: Papi, Alberto, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_gimlgs3p8nhfp7hbd26cf25bb1